Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MBRX will decline by -26.31% over the next 2 Weeks and hit $1.58 by Tuesday, August 4, 2026. In that time frame, MBRX's share price is expected to range between $1.33 and $1.82.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 4, 2026 | 1.33 | 1.58 | 1.82 |
| Aug 3, 2026 | 1.54 | 1.78 | 2.03 |
| Jul 31, 2026 | 1.57 | 1.82 | 2.05 |
| Jul 30, 2026 | 1.60 | 1.83 | 2.08 |
| Jul 29, 2026 | 1.58 | 1.82 | 2.08 |
| Jul 28, 2026 | 1.57 | 1.81 | 2.05 |
| Jul 27, 2026 | 1.79 | 2.01 | 2.24 |
| Jul 24, 2026 | 1.83 | 2.05 | 2.28 |
| Jul 23, 2026 | 1.84 | 2.06 | 2.31 |
| Jul 22, 2026 | 1.80 | 2.05 | 2.29 |
MBRX shares rose +2.79% in Wednesday, July 22, 2026's trading session, rising from a previous close of $2.15 to move at $2.21. The stock demonstrated notable intraday movement (see MBRX's key stats for a full breakdown), fluctuating between $2.16 and $2.22, a +2.69% trading range. While recent weeks have seen some volatility, MBRX has managed to secure a -6.75% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 27.41K shares changing hands, 46.31K fewer than the previous session. This amounted to $60.57K in total market activity.
Will MBRX Continue Its Downward Trend?
According to analyst ratings and projections for MBRX, Moleculin Biotech, Inc. shares are anticipated to decrease by -21.21%, potentially reaching $1.82 per share by August 4, 2026. Short-term technical indicators currently suggest a bearish sentiment for MBRX. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the MBRX stock forecast, now is not the best time to buy MBRX stock because its current trading price is +39.48% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MBRX covering social and institutional perspectives.
MBRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MBRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.65% to 43.67%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 43.75%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.13%, maintains a neutral outlook for the long term. Insights into MBRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Moleculin Biotech Short-Term Forecasts
MBRX Forecast For Next 5 Days
Our algorithm anticipates Moleculin Biotech (MBRX) stock could hit $2.66 by Jul 29, 2026. This represents a +20.16% rise from today's price, following a +5.19% change over the past five days.
MBRX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Moleculin Biotech, Inc. (MBRX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.20, which would mean a -0.45% decrease from the current price of $2.21. Projections for this period range from a high of $2.89 to a low of $1.54.
MBRX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Moleculin Biotech's price over the next three months point to a drop. MBRX stock is expected to peak at $5.23 on Jul 24, 2026 before potentially dipping to $0.00 on Oct 22, 2026. On average, MBRX is likely to trade around $0.96 in the coming 90 days.
Moleculin Biotech Stock Forecast 2025
Based on our predictive models, Moleculin Biotech (MBRX) is expected to trade between $0.00 and $5.23 throughout 2026. This would result in an average price of $0.88, potentially offering investors a -60.18% return from current levels.
Moleculin Biotech, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Moleculin Biotech, Inc. (MBRX) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $5.23, settling at an average of $1.52. This could translate to a -31.22% loss.
August 2026
Based on current market signals, Moleculin Biotech, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $4.93, with a likely average price of $0.99. Investors could expect a potential return of -55.20%.
September 2026
Our predictive algorithms indicate Moleculin Biotech, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$4.87, with an average target of $0.78. This represents a cautious outlook and a possible loss of -64.71%.
October 2026
Analyzing established trends, Moleculin Biotech, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $4.63, averaging around $0.82. This suggests a -62.90% loss from current levels.
November 2026
Market indicators suggest Moleculin Biotech, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $4.91, with a midpoint forecast of $0.81. The stock might deliver a -63.35% loss.
December 2026
Forecasting for December 2026, models estimate that Moleculin Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $5.13, averaging $0.79. This signals a cautious trajectory with potential returns around -64.25%.
January 2027
According to our latest forecast models, Moleculin Biotech, Inc. (MBRX) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $4.46, settling at an average of $0.55. This could translate to a -75.11% loss.
February 2027
Based on current market signals, Moleculin Biotech, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $4.50, with a likely average price of $0.46. Investors could expect a potential return of -79.19%.
March 2027
Our predictive algorithms indicate Moleculin Biotech, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$4.46, with an average target of $0.43. This represents a cautious outlook and a possible loss of -80.54%.
April 2027
Analyzing established trends, Moleculin Biotech, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $4.59, averaging around $0.26. This suggests a -88.24% loss from current levels.
May 2027
Market indicators suggest Moleculin Biotech, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $4.21, with a midpoint forecast of $0.23. The stock might deliver a -89.59% loss.
June 2027
Forecasting for June 2027, models estimate that Moleculin Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.14, averaging $0.13. This signals a cautious trajectory with potential returns around -94.12%.
July 2027
According to our latest forecast models, Moleculin Biotech, Inc. (MBRX) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $4.30, settling at an average of $0.14. This could translate to a -93.67% loss.
MBRX's history of dividends and stock splits also plays a role in long-term investor confidence.